Hormonal contraception as a risk factor for obesity

Medical Journal of Indonesia

Volumn 14, Issue 3, 2005, Pages 163-168

  Sugiharti, Sri ^a   Hadi, Hamam ^b   Julia, Madarina ^b  

^a Yogyakarta National Family Planning Board Office (BKKBN)   (Indonesia)

^b GADJAH MADA UNIVERSITY   (Indonesia)

Author keywords

Case control study; Family planning; Hormonal contraception; Obesity

Indexed keywords

HYDROXYPROGESTERONE CAPROATE; LEVONORGESTREL; PROGESTERONE;

ADULT; ARTICLE; BASAL METABOLIC RATE; BODY MASS; CALORIC INTAKE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; ENERGY EXPENDITURE; FEMALE; FOOD INTAKE; HIGH RISK POPULATION; HIP CIRCUMFERENCE; HORMONAL CONTRACEPTION; HUMAN; OBESITY; PREVALENCE; PROGESTIN IMPLANT; QUESTIONNAIRE; RISK FACTOR; SOCIAL PSYCHOLOGY; WAIST CIRCUMFERENCE; WAIST HIP RATIO;

EID: 85008697794     PISSN: 08531773     EISSN: 22528083     Source Type: Journal    
DOI: 10.13181/mji.v14i3.191     Document Type: Article

References (15)

1. Wilopo SA. Dinamika penurunan fertilitas dan implikasi-nya pada kebijaksanaan program KB di Indonesia. Berita Kedokteran Masyarakat X (3) 1994: 130-2.
2. Kantor Menteri Negara Kependudukan/BKKBN. Undang-undang Nomor 10 Tahun 1992 Tentang Perkembangan Kependudukan dan Pembangunan Keluarga Sejahtera Jakarta. Kantor Menteri Kependudukan. 1995. BKKBN.
3. Affandi B. Pekerja Wanita dan Keluarga Berencana. MKD vol.9, No.10/November 1990: 1990, 50-2.
4. Syaban. Rapid Survey. Pemilihan dan penggunaan alat kontrasepsi rasional di kodya Semarang, November 1991. Majalah Kesehatan Masyarakat Indonesia. Tahun XX Nomor 9, 1992: 538-41.
5. BPS. Survei Demografi dan Kesehatan Indonesia 1997. Biro Pusat Statistik Jakarta, Indonesia, 1998.
6. BKKBN. Umpan balik laporan. BKKBN. Kabupaten Kulon Progo Jogjakarta. 2001.
7. Siswosudarmo HR, Anwar HM, Emilia O. Teknologi Kontrasepsi. Gadjah Mada University Press, Jogjakarta, 2001.
8. Daphne. Drug induced nutritional deficiencies. Cornell University Ithaca. New York. 1983.
9. Katcher BS. Young Iy. Koda-Kimble MA. Applied Therapeutics. The Clinical use of Drugs. Applied Therapeutics, Inc. Spokane, 1987.
10. Sukaton. Kelainan Metabolik pada Obesitas. MKD Vol 9 No. 10 November 1990.
11. Centers for Disease Control. Epiinfo 2000 version 1.0. Atlanta Ga, 2000.
12. Stata Corporation, Intercooled Stata 6,0. USA. University Drive East, 1999.
13. Kesseru E. Aydinlik S. Etchepareborda JJ. Multicentred, phase III clinical trial of norethisterone enanthate 50 mg plus estradiol valerate 5 mg as a monthly injectable contraceptive: final three-year report. Contraception. 1994; 50:329-37.
14. Kaushik N, Depo Provera and Weight Gain. Noteworthy Nutrition papers. Vol.1. No. 1, 1998.
15. Chusman LF, Kalmuss D, Davidson AR, Heartwell S, Rulin M. Belief about Depo-Provera among three groups of contraceptors. Advances in contraception 1996; 12: 43-52.